Target intelligence / Profile preview

Default mode network (DMN)

Target
DMN
Molecular classification
Other, Large-scale intrinsic brain network
01

Overview

The Default mode network (DMN) is a large-scale, intrinsic resting-state brain network comprising primarily the medial prefrontal cortex, posterior cingulate cortex/precuneus, and lateral parietal cortex, with additional contributions from subcortical structures like the thalamus and basal forebrain. The DMN demonstrates heightened activity during internally focused cognitive processes, such as autobiographical memory, future planning, social cognition, and self-reflection, and is relatively suppressed during externally oriented, attention-demanding tasks. Disruptions in DMN connectivity are implicated in several neuropsychiatric and neurodegenerative disorders, including Alzheimer’s disease, major depression, and autism. The DMN is not a druggable molecular target, but its activity is often assessed in clinical research studying neurological and psychiatric illness.

Other names
Default networkDefault state networkMedial frontoparietal network (M-FPN)Task-negative network
02

Mechanism of action

Not applicable as a molecular target; however, modulation (e.g., increased or decreased DMN coupling/disruption) is observed in response to psychoactive drugs (e.g., psilocybin).

03

Biological functions

Self-referential processingAutobiographical memorySocial cognition (theory of mind, understanding emotions of others, moral reasoning)Episodic memory retrievalFuture planning and imaginationResting-state cognitionStory comprehensionMind-wandering
04

Disease associations

Alzheimer’s diseaseAutism spectrum disorderMajor depressive disorderSchizophreniaAttention deficit hyperactivity disorder (ADHD)Other neuropsychiatric and neurodevelopmental disorders
05

Safety considerations

No typical safety concerns as for a drug target, but the DMN’s widespread involvement in cognition means that abnormal DMN activity is associated with cognitive impairment in neurological or psychiatric illness
06

Interacting drugs

psilocybin

1 more in the full profile.

07

Biomarkers

DMN functional connectivity (measured by fMRI) is sometimes used as a biomarker of disease state or drug effects in research on neuropsychiatric disorders

Beyond the preview

Go deeper on Default mode network (DMN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Default mode network (DMN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call